MedTrace Logo

Efficacy and Safety of Specific Immunotherapy With CLUSTOID Grass Pollen

NCT01012531 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 121

Last updated 2011-07-14

No results posted yet for this study

Summary

The objective of this study is to assess the efficacy and safety of cluster immunotherapy with highly polymerized allergen extracts.

Conditions

  • Allergic Rhinitis

Interventions

BIOLOGICAL

Subcutaneous injections with highly polymerized allergen extract

cluster schedule

BIOLOGICAL

Subcutaneous injection with placebo

cluster schedule

Sponsors & Collaborators

  • Roxall Medizin

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-10-31
Primary Completion
2009-11-30
Completion
2009-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01012531 on ClinicalTrials.gov